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Abstract 
Although exposure to potentially pathogenic nontuberculous mycobacteria (NTM) via soil and 
domestic water supplies is common, pulmonary infection and disease are confined to a small 
proportion of older individuals. Previously, alleles of a polymorphism in IL10 (rs1800896) were 
associated with NTM disease and we demonstrated elevated production of IL-10 by blood leukocytes 
from patients with pulmonary NTM. Here seven additional polymorphisms in IL10 were investigated 
in a larger cohort of Caucasian controls and patients with pulmonary NTM disease. This 
demonstrated a significant association between pulmonary NTM disease and one polymorphism 
(rs1518111) in strong linkage disequilibrium with rs1800896.  
 
Introduction 
 
Pulmonary disease is the most common presentation of infections with non-tuberculous 
mycobacteria (NTM) in otherwise healthy adults, and is considered an emerging health risk in 
Australia and around the world 1, 2. Exposure through soil or water is common, but few people 
develop pulmonary NTM disease. Estimates from Queensland, Australia, suggest a frequency of 22.1 
persons per 100 000 in the population 
1
. Known risk factors for disease include smoking, excessive 
alcohol intake, past tuberculosis and underlying lung diseases such as COPD and bronchiectasis 
2, 3
. 
However these factors do not account for all cases – a notable exception being patients with the 
"Lady Windermere" phenotype. These individuals are lean and tall, with higher than normal 
incidence of thoracic abnormalities including scoliosis, pectus excavatum and mitral valve prolapse. 
The majority of pulmonary NTM cases are Caucasian (91%) and female (95%), with an average age of 
60 years 
4
. Behavioural questionnaires have found no links between pulmonary NTM disease and 
patients’ activities, exposures or habits 
4
. This implicates genetic factors in susceptibility and disease 
severity. 
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Effective Th1 and Th17 cell-mediated immune responses are crucial for the clearance of NTM 
infection and can be inhibited by IL-10 produced by Th2 cells, regulatory T-cells and macrophages 
5
. 
Hence polymorphic alleles affecting either the expression or activity of IL10 may impact upon the 
Th1/Th2/Th17 balance/response in patients of pulmonary NTM disease. Our studies of cytokine 
production by blood leukocytes from patients with pulmonary NTM disease demonstrated 
comparatively high IL-10 responses 
6
. Interferon-γ/IL-10 ratios are also associated with disease 
severity in tuberculosis, supporting a role for IL-10 in mycobacterial immunity 7. 
 
Links between allele frequencies for single nucleotide polymorphisms (SNP) within the IL10 
promoter and pulmonary NTM disease (rs1800896), asthma and tuberculosis (rs1800896, 
rs1800871, and rs1800872) have been reported 
8-11
. To further understand the influence of genetics 
on disease, seven additional SNP were typed within IL10 in an expanded cohort of patients with 
pulmonary NTM and healthy controls. SNP were chosen on the basis of previous publications 
suggesting a role in inflammatory disease &/or changing the encoded amino acid &/or location in a 
putative regulatory region. SNP that were monomorphic in Asians, Africans or Caucasians were 
excluded. 
 
 
Materials and Methods 
Patients and controls 
DNA was obtained from 124 patients with pulmonary NTM disease attending Greenslopes Private 
Hospital, QLD, Australia and Prince Charles Hospital, QLD, Australia between 2005 and 2014. NTM 
infection was diagnosed according to American Thoracic Society criteria 
12
 using radiological and 
microbiological findings. All participants provided written informed consent and the project was 
approved by the Greenslopes Research and Ethics Committee (Protocol 12/12) in accordance with 
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the National Statement on Ethical Conduct in Human Research. Two hundred and twenty nine 
control donors were recruited from Western Australia
13
 and DNA samples were provided by the 
Institute for Respiratory Health, Western Australia, in accordance with a Royal Perth Hospital Human 
Research Ethics Approval. The cohort is considered to be representative of the Caucasian Australian 
population from which patients were also derived. 
 
Genotyping 
DNA samples were quantified by fluorometry with a Qubit fluorometer (Thermo Fisher Scientific, 
Waltham, MA, USA) and adjusted to 50ng/uL. Genotyping was performed using custom TaqMan 
OpenArray Genotyping Plates (Life Technologies, Grand Island, NY, USA) 
14
. DNA samples were 
diluted at 1:1 in TaqMan OpenArray Genotyping Master Mix for 50 cycles of PCR amplification. The 
output was viewed using OpenArray™ SNP Genotyping Analysis software, and genotypes were 
allocated manually. The SNP rs3024497 was excluded as it did not meet Hardy-Weinberg Equilibrium 
(HWE). The genotyping success rate for the remaining SNP averaged 94.4 %. 
 
Data analysis 
Linkage between paired SNP alleles was determined with the use of Ensembl’s “Pairwise linkage 
disequilibrium data by population” tool with the 1000 genomes database. In this way, linkage is 
determined via both R2 and D` values for each ethnicity with available data. Statistical analyses were 
performed in Stata 12 (StataCorp, Collage Station, TX, USA). Univariate analyses evaluating 
associations between pulmonary NTM lung disease and gender, age, SNP and haplotypes were 
performed using two-tailed Fisher’s exact or Chi
2
 tests (χ2) as appropriate. Multivariate analyses 
were performed using logistic regression modelling using all included factors associated with NTM in 
univariate analyses (p < 0.20 cut-off) followed by a stepwise removal procedure to obtain the model 
of best fit. 
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Results 
The demographic profile of patients with pulmonary NTM disease 
124 patients with pulmonary NTM disease and 229 healthy controls of Caucasian ethnicity were 
recruited for genotyping. Seventy-three percent of patients and 55% of healthy controls were 
female. As this was a statistically significant difference (χ2, p = 0.001), gender was included in logistic 
regression models with SNPs of interest.  
 
NTM patients were older than healthy controls [median (range) 67 (25-89) vs. 44 (21-75) years, 
respectively]. Whilst some control donors may develop pulmonary NTM lung disease later in life, the 
impact on the data is likely to be minor as pulmonary NTM disease is rare. Patients were infected 
with M. intracellulare (n = 64), M. avium (n = 13), M. abscessus (n = 10), M. kansasii (n = 3), M. 
triplex (n = 2), M. xenopi (n = 1), M. simiae (n = 1), M. interjectum (n = 1), M. shimoidei (n = 1), M. 
terrae (n = 1), M. gordonae (n = 1), or M. lentiflavum (n = 1). Some individuals were infected with 
more than one mycobacterial species (n = 12). 
 
Associations between SNP genotypes and pulmonary NTM disease 
Of the seven SNP analysed, rs1518111 was the only marker showing a statistically significant 
association with pulmonary NTM disease (P =0.004) in univariate χ2 analysis. This withstood 
Bonferroni correction for multiple comparisons (Table 1). rs03024498 and rs1800872 displayed 
weaker associations with disease (χ2, P < 0.06). These three SNP were included in logistic regression 
models with gender. After a stepwise removal process, the final model (model p < 0001; R2 = 0.05) 
included only gender and rs1518111 (Table 2). When gender was not included, the model was 
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weakened but remained comparable, demonstrating the associations between the minor alleles of 
rs1518111 and rs3024498 with reduced and increased risk of disease (Table 2).  
 
Radiological findings available for 117 of the 124 patients were assessed for associations with alleles 
of rs1518111. Patients were sorted into nodular bronchiectasis, cavitary, or mixed diagnoses of lung 
infection. Exclusive cavitary disease was more common in patients carrying the minor allele (A) at 
rs1518111 (χ2, P = 0.001). However, when patients with a mixed radiological diagnosis (featuring 
cavitairy and nodular bronchiectasis together) are included in analysis, the trend is no longer 
significant (χ2, P = 0.079). The isolation of fast (n=9) or slow (n=86) growing mycobacteria from the 
lung were also tested for associations with alleles of rs1518111. A weak association was observed 
between fast growing NTM species and carriage of the minor allele (χ2, P = 0.07). 
 
Discussion 
 
The minor (A) allele of rs1518111 (previously denoted rs3748675) was associated with reduced risk 
of pulmonary NTM disease. This minor (A) allele has been linked to increased incidence of Behcet’s 
disease in a Turkish cohort 15,  reduced risk of prostate hyperplasia in a Korean cohort 16, and 
increased risk of tuberculosis (as part of a three SNP haplotype) in an Ugandan cohort 
17
. The allele is 
also associated with lower IL-10 plasma concentrations, poor treatment outcome and enhanced 
systemic inflammation in patients with acute coronary syndrome in a Swedish cohort 18.  Studies 
investigating this allele as a contributing factor to disease identify associations with pro-
inflammatory tendencies in patients, suggesting a modified IL-10 response. Our study implicates the 
minor (A) allele of rs1518111 in risk of pulmonary NTM disease in Caucasians.  
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Ethnicity is an important consideration because the frequency of the A allele of rs1518111 varies 
between different ethnicities, from 22% in Europeans (EUR) to 68% in East Asians (EAS) 
19
. rs1518111 
is in linkage disequilibrium with rs1800896 in all ethnicities covered by the 1000 Genomes database 
(D’ > 0.99) 19. However R2 values range from 0.095 (Chinese Dai in Xishuangbanna, China) to 0.420 
(Mandinka, Western Gambia). The minor (C) allele of rs1800896 is usually inherited with the minor 
(A) allele of rs1518111, but rs1800896 has a higher MAF. Both alleles have now been associated with 
NTM disease 
8
, demonstrating the existence of an IL10 haplotype which could affect the ability of an 
individual to respond effectively to pulmonary NTM infection.  In individuals from the control 
population used in our study, a haplotype spanning the promotor region of IL10 affected 
transcription regulation in peripheral blood cells stimulated with Streptococcus pneumonia 
13
. The 
two SNP associated here with NTM disease (rs1800896 and rs1800872) were in complete linkage 
disequilibrium 
13
. In South African HIV patients, rs1800896 
20
 and rs1518111 have been associated 
with peripheral neuropathy (Goullee et al, unpublished data), providing another link between these 
alleles and inflammatory disease. Unfortunately the linkage disequilibrium confounds 
determinations of which SNP affect IL-10 levels in vivo.   
 
Radiological data was available for a subset of the patients used in this study. Amongst these, 
carriage of the minor (A) allele at rs1518111 correlated with a presentation of cavitary disease (as 
opposed to nodular bronchiectasis) so the immunopathology of these presentations may vary. 
Infection with fast and slow growing NTM species is independent of radiological presentation and 
only weakly associated with the IL10 genotype. 
 
In conclusion, when compared with a healthy control group, patients with pulmonary NTM disease 
were less likely to carry the minor (A) allele for the IL10 SNP rs1518111, which is in linkage 
disequilibrium with rs1800896 – a SNP previously associated with NTM disease. Our review of the 
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literature associates these alleles with low levels of IL-10 and enhanced risk of inflammatory 
conditions. 
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Table 1: rs1518111 was significantly associated with NTM disease in univariate analyses 
SNP  a 
Chr. 1 
Position 
MA 
MAF 
b
 
Control 
MAF 
b 
NTM 
P-value 
(χ
2
) 
   (n = 229) (n = 124)  
rs3024498 206941529 G 43.7% 54.9% 0.054 
rs1518111 206944645 A 43.7% 27.6% 0.004 
rs3021094 206944952 C 15.7% 18.5% 0.52 
rs3024491 206945046 G 27.0% 22.1% 0.32 
rs1800872 206946407 A 46.4% 35.8% 0.058 
rs1800871 206946634 T 46.6% 38.5% 0.15 
a 
SNP are shown in chromosomal order. 
b 
Minor allele frequencies are based on individuals successfully genotyped  
 
 
 
 
Table 2: Logistic regression models define gender and rs1518111 predict NTM disease. 
 
Variable Odds Ratio P-value 95% confidence interval 
Model combining gender and SNP (n = 338 a, p < 0.0001; R2 = 0.05) 
Gender  0.44 0.001 0.266-0.718 
rs1518111  0.507 0.007 0.309-0.830 
Model combining SNP (n = 315
 a
, p = 0.0087; R
2
 = 0.02) 
rs3024498 1.37 0.205 0.840-2.251 
rs1518111
 b
 0.540 0.021 0.320-0.910 
a 
excluding samples with genotyping failures. 
 
 
